
    
      To evaluate the role of 4-AP on the recovery of nerve function we will be giving patients
      with prostate cancer who are undergoing robot assisted radical prostatectomy (RP) either 4-AP
      or placebo in the perioperative period. This population of patients was selected as nerve
      crush injury during RP is thought to contribute to erectile dysfunction and urinary
      continence post operatively.
    
  